MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
American Heart Journal
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,105 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,105 works in the cohort · of 4,299,418page 14 of 23

Labels cover 0 of 1,105 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,105 of 1,105 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Long-term outcomes for women versus men with unstable angina/non–ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial
Peter Clemmensen, Matthew T. Roe, Judith S. Hochman, Derek D. Cyr, Megan L. Neely, Darren K. McGuire +8 more
2015· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
23
citations
affno abstractunlabeled
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: A substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial
Rudolf Járai, Kurt Huber, Kris Bogaerts, Walter Droogné, Justin A. Ezekowitz, Christopher B. Granger +5 more
2009· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
22
citations
affno abstractunlabeled
Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both
Keith A.A. Fox, Sonia S. Anand, Victor Aboyans, Martín Cowie, E. Sebastian Debus, Uwe Zeymer +4 more
2020· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
21
citations
affno abstractunlabeled
Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial
Abhinav Sharma, Flávio de Souza Brito, Jie‐Lena Sun, Laine Thomas, Steven M. Haffner, Rury R. Holman +1 more
2016· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
21
citations
affno abstractunlabeled
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux
Philippe Gabríel Steg, Shamir R. Mehta, Sanjit S. Jolly, Denis Xavier, Hans-Juergen Rupprecht, José López‐Sendón +6 more
2010· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
20
citations
20
citations

How this was built: Screen · Findings · About